Evaluation of periostin levels in gingival crevicular fluid and peri-implant sulcus fluid in patients with periodontal and peri-implanter disease: A cross-sectional study

Aim: Periodontal and peri-implanter diseases are chronic, infectious and inflammatory diseases that manifest as a result of therelationship between their primary etiologic factor, i.e. microbial dental plaque, and the host defense system. Periostin is a proteinthat has been shown to play a functional role in wound repair, cardiovascular diseases, bone and tooth regeneration and toothmorphogenesis. In this study, the aim was to understand the role of periostin in periodontal (Gingivitis and Periodontitis) and periimplant (Peri-implant mucositis and Peri-implantitis) disease.Material and Methods: Forty-two subjects were enrolled in this cross-sectional study. In the clinical measurements, PPD, GI and PIvalues were measured from the implants and natural teeth. Peri-implant sulcus and gingival crevicular fluids were collected from thepatients using paper strips. Periostin levels were measured using ELISA. All parameter was statistically tested by using third partysoftware (SPSS v24.)Results: In terms of PPD, there was a statistically significant difference between the gingivitis-periodontitis, gingivitis-periimplantitis, peri-implant mucositis-periodontitis and peri-implant mucositis-peri-implantitis groups. There was a statisticallysignificant difference between the gingivitis-periodontitis, gingivitis-peri-implantitis and peri-implant mucositis-peri-implantitisgroups in terms of GCF/PISF volume. Although there was no statistically significant difference between the groups in terms of theamount of GCF/PISF periostin, periostin values were higher in peri-implant mucositis and gingivitis samples as compared to theperi-implantitis and periodontitis groups.Conclusion: Clinical parameters are a valid diagnostic tool for peri-implanter disease; there is a need for multicenter studies tounderstand the inflammatory basis of peri-implanter diseases that are biochemically prospective.

PDF

___

1 Newman MG, Takei H, Klokkevold PR CF 2011. CCP. No Titl. 2 Becker W, Hujoel P, Becker BE, et al. Dental implants in an aged population: evaluation of periodontal health, bone loss, implant survival, and quality of life. Clin Implant Dentistry Related Res 2016;18:473–9.
3 Feine J, Abou-Ayash S, Al Mardini M, et al. Group 3 ITI Consensus Report: Patient-reported outcome measures associated with implant dentistry. Clinical Oral Implants Research 2018;29:270–5.
4 Heitz-Mayfield LJA, Salvi GE. Peri-implant mucositis. J Periodontol 2018;89:257–66.
5 Salvi GE, Aglietta M, Eick S, et al. Reversibility of experimental peri-implant mucositis compared with experimental gingivitis in humans. Clin Oral Implant Res 2012;23:182–90.
6 Schwarz F, Derks J, Monje A, Wang H-L. Peri-implantitis. J Periodontol 2018;89:267–90.
7 Salvi GE, Cosgarea R, Sculean A. Prevalence and mechanisms of peri-implant diseases. J Dental Res 2017;96:31–7.
8 Heitz-Mayfield LJA, Lang NP. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontology 2010;53:167–81.
9 Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends in Immunology 2014;35:3–11.
10 Ülker AE, Tulunoglu Ö, Özmeric N, et al. The Evaluation of Cystatin C, IL-1β, and TNF-α Levels in Total Saliva and Gingival Crevicular Fluid From 11- to 16-Year-Old Children. J Periodontol 2008;79:854–60.
11 Faot F, Nascimento GG, Bielemann AM, et al. Can peri-implant crevicular fluid assist in the diagnosis of peri-implantitis? A systematic review and meta-analysis. J Periodontol 2015;86:631–45.
12 Trombelli L, Farina R, Silva CO, et al. Plaque-induced gingivitis: Case definition and diagnostic considerations. J Clin Periodontol 2018;45:S44–67. 13 Lang NP, Bartold PM. Periodontal health. J Periodontol 2018; 89:9–16.
14 Sánchez-Siles M, Lucas-Azorin J, Salazar-Sánchez N, et al. Salivary Concentration of Oxidative Stress Biomarkers in a Group of Patients with Peri-Implantitis: A Transversal Study. Clin Implant Dentist Related Res 2016;18:1015–22.
15 Gürlek Ö, Gümüş P, Nile CJ, Lappin DF, Buduneli N. Biomarkers and bacteria around implants and natural teeth in the same individuals. J Periodontol 2017;88:752–61.
16 Bhardwaj S, Prabhuji MLV. Comparative volumetric and clinical evaluation of peri-implant sulcular fluid and gingival crevicular fluid. J Periodontal Implant Sci 2013;43:233.
17 Plagnat D, Giannopoulou C, Carrel A, et al. Elastase, α2- macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis. Clin Oral Implant Res 2002;13:227–33.
18 Basegmez C, Yalcin S, Yalcin F, et al. Evaluation of periimplant crevicular fluid prostaglandin E2 and matrix metalloproteinase-8 levels from health to periimplant disease status. Implant Dentistry 2012; 21:306–10.
19 Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblastspecific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochemical J 1993;294:271–8.
20 Rios HF, Bonewald LF, Conway SJ. Lessons from the matricellular factor periostin. J Dental Res 2014;93:843–5.
21 Bonewald LF, Dallas SL. Role of active and latent transforming growth factor β in bone formation. J Cellular Biochemist 1994; 55:350–7.
22 Kii I, Amizuka N, Minqi L, et al. Periostin is an extracellular matrix protein required for eruption of incisors in mice. Biochemical Biophys Res Communicat 2006;342:766–72.
23 Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int 2012;3:1199–212.
24 Padial-Molina M, Volk SL, Rodriguez JC, et al. Tumor Necrosis Factor-α and Porphyromonas gingivalis Lipopolysaccharides Decrease Periostin in Human Periodontal Ligament Fibroblasts. Journal of Periodontology 2013; 84 (5):694–703.
25 Balli U, Keles ZP, Avci B, et al. Assessment of periostin levels in serum and gingival crevicular fluid of patients with periodontal disease. J Periodontal Res 2015;50:707–13.
26 Sanz M, Chapple IL, Working Group 4 of the VIII European Workshop on Periodontology. Clinical research on periimplant diseases: consensus report of Working Group 4. J Clin Periodontol 2012;39:202–6.
27 Offenbacher S, Barros S, Mendoza L, et al. Changes in gingival crevicular fluid inflammatory mediator levels during the induction and resolution of experimental gingivitis in humans. J Clin Periodontol 2010;37:324–33.
28 Thunell DH, Tymkiw KD, Johnson GK, et al. A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res 2010;45:148–52.
29 Rios H, Koushik SV, Wang H, et al. periostin Null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Molecular Cellular Biology 2005;25:11131–44.
30 Guo S, Kang J, Ji B, et al. Periodontal-derived mesenchymal cell sheets promote periodontal regeneration in inflammatory microenvironment. Tissue engineering Part A 2017;23:585– 96.
31 Aral CA, Köseoğlu S, Sağlam M, et al. Gingival crevicular fluid and salivary periostin levels in non-smoker subjects with chronic and aggressive periodontitis. Inflammation 2016;39:986–93.
32 Akman AC, Askin SB, Guncu GN, et al. Evaluation of gingival crevicular fluid and peri-implant sulcus fluid levels of periostin: A preliminary report. J Periodontol 2017;1–11.
33 Padial-Molina M, Volk SL, Taut AD, et al. Periostin is Downregulated during Periodontal Inflammation. J Dental Res 2012; 1:1078–84.
34 Padial-Molina M, Volk SL, Rios HF. Preliminary insight into the periostin leverage during periodontal tissue healing. J Clin Periodontol 2015;42:764–72.
35 Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontology 2000 2003; 31:32–42.